Adam Hansard - Chief Commercial Officer at Applied Therapeutics, Inc.

Issuer-level insider activity

Role
Chief Commercial Officer
Issuer ticker
APLT
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Adam Hansard since 17 Aug 2025

Reported holdings for Adam Hansard in Applied Therapeutics, Inc.

Form 4 holding Chief Commercial Officer

Applied Therapeutics, Inc.

Security class
Common Stock
Shares / value
732,919
Estimated value
$3,950,433
Report date
14 Mar 2024
Price
$5.39
Ownership
Direct

Transaction history for Adam Hansard in Applied Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .